Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study (Q56706209)

From Wikidata

Jump to navigation Jump to search

scientific article published in The Lancet

Language	Label	Description	Also known as
English	Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study	scientific article published in The Lancet

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Daniela Toneatto

7

object named as

Daniela Toneatto

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

María Elena Santolaya

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Miguel L O'Ryan

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

María Teresa Valenzuela

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Valeria Prado

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Rodrigo Vergara

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Alma Muñoz

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Gabriela Graña

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Huajun Wang

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ralf Clemens

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Peter M Dull

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

V72P10 Meningococcal B Adolescent Vaccine Study group

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

18 January 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

379

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

9816

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

617-624

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Global epidemiology of meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in the development of vaccines against Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Conquering the meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and safety of an investigational quadrivalent meningococcal ACWY tetanus toxoid conjugate vaccine in healthy adolescents and young adults 10 to 25 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Serogroup B meningococcal vaccines-an unfinished story

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of meningococcal group B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A universal vaccine for serogroup B meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningoc

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961713-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(11)61713-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260988%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56706209&oldid=1875249494"